Related Experiment Video
Updated: Jul 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Genetic background determines response to hemostasis and thrombosis
Jane Hoover-Plow1, Aleksey Shchurin, Erika Hart
1Department of Cardiovascular Medicine, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Ohio, USA. hooverj@ccf.org
Insights
Genetic background significantly impacts thrombosis and hemostasis. A/J mice show increased rebleeding compared to C57BL/6J mice, with specific chromosomes influencing this phenotype.
Area of Science:
- Cardiovascular Biology
- Genetics
- Hemostasis and Thrombosis
Background:
- Thrombosis is a major cause of cardiovascular disease mortality.
- C57BL/6J and A/J mice exhibit distinct differences in cardiovascular phenotypes.
- The influence of genetic background on thrombosis and hemostasis pathways is not fully understood.
Purpose of the Study:
- To investigate thrombosis and hemostasis differences between C57BL/6J and A/J mice.
- To identify genetic loci controlling these phenotypes using chromosome substitution strains.
Main Methods:
- Ferric chloride-induced carotid artery thrombosis model to measure occlusion time.
- Tail bleeding and rebleeding assays as hemostasis markers.
- Screening of 21 A/J chromosome substitution strains on a C57BL/6J background.
Main Results:
- A/J mice exhibited decreased thrombus occlusion time and increased rebleeding time compared to C57BL/6J mice.
- Tail collagen content was higher in A/J mice.
- Three chromosome substitution strains (B6-Chr5A/J, B6-Chr11A/J, B6-Chr17A/J) showed increased rebleeding, similar to A/J mice.
Conclusions:
- Genetic background significantly influences arterial thrombosis and hemostasis.
- Specific A/J chromosomes (5 and 17) contribute to increased rebleeding.
- Identifying genetic determinants of thrombotic risk is feasible through these models.
Background:
Thrombosis is the fatal and disabling consequence of cardiovascular diseases, the leading cause of mortality and morbidity in Western countries. Two inbred mouse strains, C57BL/6J and A/J, have marked differences in susceptibility to obesity, atherosclerosis, and vessel remodeling. However, it is unclear how these diverse genetic backgrounds influence pathways known to regulate thrombosis and hemostasis. The objective of this study was to evaluate thrombosis and hemostasis in these two inbred strains and determine the phenotypic response of A/J chromosomes in the C57BL/6J background.
Methods:
A/J and C57Bl/6J mice were evaluated for differences in thrombosis and hemostasis. A thrombus was induced in the carotid artery by application of the exposed carotid to ferric chloride and blood flow measured until the vessel occluded. Bleeding and rebleeding times, as surrogate markers for thrombosis and hemostasis, were determined after clipping the tail and placing in warm saline. Twenty-one chromosome substitution strains, A/J chromosomes in a C57BL/6J background, were screened for response to the tail bleeding assay.
Results:
Thrombus occlusion time was markedly decreased in the A/J mice compared to C57BL/6J mice. Tail bleeding time was similar in the two strains, but rebleeding time was markedly increased in the A/J mice compared to C57BL/6J mice. Coagulation times and tail morphology were similar, but tail collagen content was higher in A/J than C57BL/6J mice. Three chromosome substitution strains, B6-Chr5A/J, B6-Chr11A/J, and B6-Chr17A/J, were identified with increased rebleeding time, a phenotype similar to A/J mice. Mice heterosomic for chromosomes 5 or 17 had rebleeding times similar to C57BL/6J mice, but when these two chromosome substitution strains, B6-Chr5A/J and B6-Chr17A/J, were crossed, the A/J phenotype was restored in these doubly heterosomic progeny.
Conclusion:
These results indicate that susceptibility to arterial thrombosis and haemostasis is remarkably different in C57BL/and A/J mice. Three A/J chromosome substitution strains were identified that expressed a phenotype similar to A/J for rebleeding, the C57Bl/6J background could modify the A/J phenotype, and the combination of two A/J QTL could restore the phenotype. The diverse genetic backgrounds and differences in response to vascular injury induced thrombosis and the tail bleeding assay, suggest the potential for identifying novel genetic determinants of thrombotic risk.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Principles of Pharmacogenetics: Types of Genetic Variants